Martin Preyer

Executive Director Biotherapeutics @EvolveImmune Therapeutics

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2024 — Present

Executive Director Biotherapeutics @EvolveImmune Therapeutics

View department →

EDUCATION

1995 — 2002

University of Natural Resources and Life Sciences, Vienna (BOKU)

Diploma Engineer, Food Chemistry and Biotechnology

2002 — 2007

University of Natural Resources and Life Sciences, Vienna (BOKU)

Dr. nat. techn.

SKILLS

Molecular CloningBiochemistryViral VectorsGeneticsLife SciencesAntibodiesLaboratory SkillsMolecular BiologyFluorescence MicroscopyLaboratoryDrug DiscoveryCell BiologyPharmacologyCell CultureMammalian Cell CultureProtein ChemistryCancer BiologyBiotechnologyAssay Development

ABOUT MARTIN PREYER

Visionary biologics drug discovery leader with deep expertise in antibody engineering, bispecific antibodies, antibody-drug conjugates, and a strong background in cancer and immuno-oncology• Driver of innovation with a track record of inventing bispecifics and multifunctional antibody platform technologies as supported by patents and publications• Proven manager successfully mentoring and developing individuals and leading multidisciplinary drug discovery teams from initiation to preclinical development• Excellent communicator and effective presenter to internal stakeholders, executive leadership teams as well as external audiences and investors• Recognized as outstanding collaborator in cross-functional biologics drug discovery teams across various therapeutic areas

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.